aHIF [104], APOA1 antisense RNA (APOA1-AS) [104], lncRNA associated with poor prognosis of hepatocellular carcinoma (AWPPH) [113], KCNQ1 opposite strand/antisense transcript 1 (KCNQ1OT1) [104], and LIPCAR [141] are others prominent lncRNAs to be used in clinical settings as biomarkers for diagnosis and monitoring of CHD. This evidence concerns the gene APOA1 and hepatocellular carcinoma.